Enclomiphene therapy is an excellent option for individuals suffering from low testosterone levels, but are not ready to commit to testosterone replacement therapy (TRT)
Ideal candidates may include: Adults with type 2 diabetes who are not reaching their HbA1c targets with other therapies Individuals with obesity or overweight (with or without diabetes) Patients who require additional metabolic support for conditions like high cholesterol or hypertension However, it is not suitable for everyone
Insulin resistance, chronic inflammation, hormonal imbalance, gut dysfunction, nutrient deficiencies, disrupted sleep, and lifestyle factors continue to shape long-term metabolic healthregardless of appetite suppression alone (9)
Manufacturer savings cards Novo Nordisk and Eli Lilly both offer Savings Card programs for their GLP-1s, including their weight loss injections
PCOS A small 2023 study followed 27 women with obesity and PCOS who hadnt lost weight with lifestyle changes